SecBot SecBot
Insider Cluster (2 insiders) ·Filed Mar 27, 2026

ANAB

ANAPTYSBIO, INC
BEARISH
Impact 7/10
Horizonweeks Processed7mo ago
Insider cluster: 2 insiders, $731K total
Actionable Insight ▼ Bearish

The proximity of insider selling to a major corporate action (spin-off + private placement) raises concerns about insider sentiment ahead of structural changes. Traders should monitor for further selling, delays in the Form 10 filing for the spin-off, or downward revisions to guidance. Consider hedging ahead of spin-off execution.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$38.27
T+0 close · Mar 26, 2026 · via day close
Latest settled
+53.87%
T+60 · $58.88
Vs SPY
+37.80%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 27 $38.27entry
  2. T+1 · 8mo ago −3.50%α −3.14% · $36.93
  3. T+5 · 8mo ago +8.76%α +4.90% · $41.62
  4. T+20 · 7mo ago +74.02%α +61.27% · $66.59
  5. T+60 · 5mo ago +53.87%α +37.80% · $58.88
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two corporate insiders at AnaptysBio sold shares worth $731K within a 7-day window, including CEO Daniel Faga and Director John Schmid, shortly after the company announced a securities purchase agreement related to a spin-off of its subsidiary First Tracks Biotherapeutics. The timing suggests potential awareness of material non-public developments.

Key Financial Metrics

Direction
selling
Total Value
$731.0K
Insiders
2

Key Facts

  • CEO Daniel Faga and Director John Schmid sold a combined $731K in shares over 7 days
  • Sales occurred between March 27 and March 30, 2026, immediately following an 8-K filing disclosing a material agreement for a spin-off and private placement
  • Total insider selling represents approximately 0.046% of AnaptysBio's $1.6B market cap
  • The 8-K (filed March 27) disclosed a securities purchase agreement for First Tracks Biotherapeutics, a wholly-owned subsidiary, to be spun off to AnaptysBio shareholders

Financial Impact

$731,000 in open-market sales by two insiders

insider sentimentshareholder confidencepotential dilution perception

Risk Factors

  • Insider selling may signal lack of confidence in post-spin valuation or near-term prospects
  • Private placement concurrent with spin-off could lead to dilution or perceived value transfer
  • Regulatory or operational risks associated with the spin-off execution

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ANAB-1775093331565

Track record

28 reports on ANAB

Performance horizon

9 of 18 bullish or bearish reports moved the stock their way by T+1. Best: +41.26% at T+60 after the Mar 3, 2026 report. 12 of 18 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $46.25 Now $45.73 −1.12% settles Nov 17
  2. Nov 12, 20264d ago Press Release Bearish 4/10 Entry $46.25 to $45.73 Now $45.73 +1.12% ▲ +1.12% −0.79% vs SPY
  3. Nov 6, 202610d ago Institutional Cluster Neutral 2/10 Entry $46.45 to $47.97 Now $45.73 −1.55% ▲ +3.27% +0.91% vs SPY
  4. Sep 21, 20268w ago Press Release Neutral 5/10 Entry $53.92 to $50.77 Now $45.73 −15.19% ▼ −5.84% −5.12% vs SPY
  5. Aug 12, 202613w ago Institutional Cluster Bullish 5/10 Entry $56.02 to $58.47 Now $45.73 −18.37% ▲ +4.37% +4.57% vs SPY
  6. Jun 29, 202620w ago 144 Bearish 6/10 Entry $67.50 to $65.43 Now $45.73 +32.25% ▲ +3.07% +2.93% vs SPY
  7. Jun 29, 202620w ago DEFA14A Neutral 2/10 Entry $67.50 to $65.43 Now $45.73 −32.25% ▼ −3.07% −2.93% vs SPY
  8. Jun 26, 202620w ago 144 Bearish 6/10 Entry $65.97 to $67.50 Now $45.73 +30.68% ▼ −2.32% −1.54% vs SPY
  9. Jun 22, 202621w ago 8-K Neutral 2/10 Entry $59.43 to $58.48 Now $45.73 −23.05% ▼ −1.60% −1.55% vs SPY
  10. Jun 17, 202621w ago 144 Bearish 5/10 Entry $57.51 to $59.99 Now $45.73 +20.48% ▼ −4.31% −4.63% vs SPY
Showing 10 of 28

US Market Status

Market Closed · Opens in 6h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 1, 2026